{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:18:00Z","timestamp":1784913480771,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10002-8","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T09:04:07Z","timestamp":1776675847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MCT4 deficiency suppresses tumor incidence and metastasis by downregulating IGF1 expression and enhancing anti-tumor immunity"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6275-9675","authenticated-orcid":false,"given":"Shuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9590-7407","authenticated-orcid":false,"given":"Xiaoju","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4907-4235","authenticated-orcid":false,"given":"Ningning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"10002_CR1","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"10002_CR2","doi-asserted-by":"crossref","unstructured":"Gupta, S., Roy, A. & Dwarakanath, B. S. Metabolic cooperation and competition in the tumor microenvironment: implications for therapy. Front. Oncol. 7, 68 (2017).","DOI":"10.3389\/fonc.2017.00068"},{"key":"10002_CR3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader, J. E., Voss, K. & Rathmell, J. C. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Molecular Cell 78, 1019\u20131033 (2020).","journal-title":"Molecular Cell"},{"key":"10002_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti, M. V. & Locasale, J. W. The Warburg Effect: How does it benefit cancer cells? Trends in Biochemical Sciences 41, 211\u2013218 (2016).","journal-title":"Trends in Biochemical Sciences"},{"key":"10002_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. & Thompson, C. B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metabolism 7, 11\u201320 (2008).","journal-title":"Cell Metabolism"},{"key":"10002_CR6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1124\/pr.119.018762","volume":"72","author":"MA Felmlee","year":"2020","unstructured":"Felmlee, M. A., Jones, R. S., Rodriguez-Cruz, V., Follman, K. E., Morris, M. E. & Daws, L. C. Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease. Pharmacological Reviews 72, 466\u2013485 (2020).","journal-title":"Pharmacological Reviews"},{"key":"10002_CR7","first-page":"3930","volume":"118","author":"P Sonveaux","year":"2009","unstructured":"Sonveaux, P. et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. Journal of Clinical Investigation 118, 3930\u20133942 (2009).","journal-title":"Journal of Clinical Investigation"},{"key":"10002_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gendis.2017.02.003","volume":"4","author":"B Jiang","year":"2017","unstructured":"Jiang, B. Aerobic glycolysis and high level of lactate in cancer metabolism and microenvironment. Genes & Diseases 4, 25\u201327 (2017).","journal-title":"Genes & Diseases"},{"key":"10002_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","volume":"33","author":"VL Payen","year":"2020","unstructured":"Payen, V. L., Mina, E., Van H\u00e9e, V. F., Porporato, P. E. & Sonveaux, P. Monocarboxylate transporters in cancer. Molecular Metabolism 33, 48\u201366 (2020).","journal-title":"Molecular Metabolism"},{"key":"10002_CR10","doi-asserted-by":"publisher","first-page":"20135","DOI":"10.1074\/jbc.RA119.009093","volume":"294","author":"Y Contreras-Baeza","year":"2019","unstructured":"Contreras-Baeza, Y. et al. Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments. Journal of Biological Chemistry 294, 20135\u201320147 (2019).","journal-title":"Journal of Biological Chemistry"},{"key":"10002_CR11","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.3390\/ijms19113317","volume":"19","author":"K Hasegawa","year":"2018","unstructured":"Hasegawa, K. et al. Lactate transporter monocarboxylate transporter 4 induces bone pain in head and neck squamous cell carcinoma. International Journal of Molecular Sciences 19, 3317 (2018).","journal-title":"International Journal of Molecular Sciences"},{"key":"10002_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/cts.12551","volume":"11","author":"P Fisel","year":"2018","unstructured":"Fisel, P., Schaeffeler, E. & Schwab, M. Clinical and functional relevance of the monocarboxylate transporter family in disease pathophysiology and drug therapy. Clinical and Translational Science 11, 352\u2013364 (2018).","journal-title":"Clinical and Translational Science"},{"key":"10002_CR13","doi-asserted-by":"publisher","first-page":"245 e249","DOI":"10.1016\/j.urology.2014.03.031","volume":"84","author":"JW Choi","year":"2014","unstructured":"Choi, J. W., Kim, Y., Lee, J. H. & Kim, Y. S. Prognostic significance of lactate\/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder. Urology 84, 245 e249\u2013215 (2014).","journal-title":"Urology"},{"key":"10002_CR14","doi-asserted-by":"publisher","first-page":"e87904","DOI":"10.1371\/journal.pone.0087904","volume":"9","author":"J Zhu","year":"2014","unstructured":"Zhu, J. et al. Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients. PLoS One 9, e87904 (2014).","journal-title":"PLoS One"},{"key":"10002_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4081\/oncol.2019.403","volume":"13","author":"A Javaeed","year":"2019","unstructured":"Javaeed, A. & Ghauri, S. K. MCT4 has a potential to be used as a prognostic biomarker - a systematic review and meta-analysis. Oncology Reviews 13, 403 (2019).","journal-title":"Oncology Reviews"},{"key":"10002_CR16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/j.1349-7006.2011.01908.x","volume":"102","author":"H Izumi","year":"2011","unstructured":"Izumi, H. et al. Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Science 102, 1007\u20131013 (2011).","journal-title":"Cancer Science"},{"key":"10002_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.37349\/etat.2024.00210","volume":"5","author":"T Koltai","year":"2024","unstructured":"Koltai, T. & Fliegel, L. Exploring monocarboxylate transporter inhibition for cancer treatment. Exploration of Targeted Anti-tumor Therapy 5, 135\u2013169 (2024).","journal-title":"Exploration of Targeted Anti-tumor Therapy"},{"key":"10002_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112393","volume":"199","author":"S Puri","year":"2020","unstructured":"Puri, S. & Juvale, K. Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights. European Journal of Medicinal Chemistry 199, 112393 (2020).","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10002_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.omto.2020.06.012","volume":"18","author":"T-C Kuo","year":"2020","unstructured":"Kuo, T.-C. et al. Monocarboxylate transporter 4 is a therapeutic target in non-small cell lung cancer with aerobic glycolysis preference. Molecular Therapy - Oncolytics 18, 189\u2013201 (2020).","journal-title":"Molecular Therapy - Oncolytics"},{"key":"10002_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3892\/ol.2020.12305","volume":"21","author":"X Li","year":"2020","unstructured":"Li, X. et al. Overexpression of monocarboxylate transporter 4 promotes the migration and invasion of non\u2011carcinogenic L929 fibroblast cells. Oncology Letters 21, 44 (2020).","journal-title":"Oncology Letters"},{"key":"10002_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3892\/ol.2023.14047","volume":"26","author":"X Zhou","year":"2023","unstructured":"Zhou, X. et al. Monocarboxylate transporter 4 promotes the migration of non\u2011cancerous L929 fibroblast cells by activating the IGF1\/IGF1R\/PIK3R3\/SGK1 axis. Oncology Letters 26, 460 (2023).","journal-title":"Oncology Letters"},{"key":"10002_CR22","doi-asserted-by":"publisher","first-page":"C414","DOI":"10.1152\/ajpcell.00430.2008","volume":"296","author":"SM Gallagher","year":"2009","unstructured":"Gallagher, S. M., Castorino, J. J. & Philp, N. J. Interaction of monocarboxylate transporter 4 with \u03b21-integrin and its role in cell migration. American Journal of Physiology-Cell Physiology 296, C414\u2013C421 (2009).","journal-title":"American Journal of Physiology-Cell Physiology"},{"key":"10002_CR23","doi-asserted-by":"crossref","unstructured":"Tang C.-H., et al. Monocarboxylate Transporter 4 Facilitates Cell Proliferation and Migration and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma Patients. PLoS ONE 9, e87904(2014).","DOI":"10.1371\/journal.pone.0087904"},{"key":"10002_CR24","first-page":"187","volume":"18","author":"Q Sun","year":"2019","unstructured":"Sun, Q., Hu, L. -l & Fu, Q. MCT4 promotes cell proliferation and invasion of castration\u2011resistant prostate cancer PC\u20113 cell line. EXCLI Journal 18, 187\u2013194 (2019).","journal-title":"EXCLI Journal"},{"key":"10002_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/JHC.S352948","volume":"9","author":"Z Niu","year":"2022","unstructured":"Niu, Z. et al. MCT4 Promotes hepatocellular carcinoma progression by upregulating TRAPPC5 gene. Journal of Hepatocellular Carcinoma 9, 289\u2013300 (2022).","journal-title":"Journal of Hepatocellular Carcinoma"},{"key":"10002_CR26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. obertA. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"10002_CR27","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","volume":"191","author":"Z Husain","year":"2013","unstructured":"Husain, Z., Huang, Y., Seth, P. & Sukhatme, V. P. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells. The Journal of Immunology 191, 1486\u20131495 (2013).","journal-title":"The Journal of Immunology"},{"key":"10002_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.901495","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Lactate: the mediator of metabolism and immunosuppression. Frontiers in Endocrinology 13, 901495 (2022).","journal-title":"Frontiers in Endocrinology"},{"key":"10002_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia, L. et al. The cancer metabolic reprogramming and immune response. Mol Cancer 20, 28 (2021).","journal-title":"Mol Cancer"},{"key":"10002_CR30","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.ccell.2023.05.015","volume":"41","author":"Y Qian","year":"2023","unstructured":"Qian, Y. et al. MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma. Cancer Cell 41, 1363\u20131380.e1367 (2023).","journal-title":"Cancer Cell"},{"key":"10002_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/hep.32348","volume":"77","author":"Y Fang","year":"2023","unstructured":"Fang, Y. et al. Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack. Hepatology 77, 109\u2013123 (2023).","journal-title":"Hepatology"},{"key":"10002_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2024.100625","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy, B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. The Innovation 5, 100625 (2024).","journal-title":"The Innovation"},{"key":"10002_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.apsb.2019.12.006","volume":"10","author":"W Song","year":"2020","unstructured":"Song, W., Li, D., Tao, L., Luo, Q. & Chen, L. Solute carrier transporters: the metabolic gatekeepers of immune cells. Acta Pharmaceutica Sinica B 10, 61\u201378 (2020).","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10002_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.238","volume":"3","author":"D Chen","year":"2024","unstructured":"Chen, D. et al. Sangerbox 2: Enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform. Imeta 3, e238 (2024).","journal-title":"Imeta"},{"key":"10002_CR35","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.2147\/IJN.S284560","volume":"16","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Downregulation of hsa_circ_0074854 suppresses the migration and invasion in hepatocellular carcinoma via interacting with HuR and via suppressing exosomes-mediated macrophage M2 polarization. International Journal of Nanomedicine 16, 2803\u20132818 (2021).","journal-title":"International Journal of Nanomedicine"},{"key":"10002_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","volume":"29","author":"K Kohli","year":"2021","unstructured":"Kohli, K., Pillarisetty, V. G. & Kim, T. S. Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Therapy 29, 10\u201321 (2021).","journal-title":"Cancer Gene Therapy"},{"key":"10002_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga, A. J., Chow, M. T. & Luster, A. D. Chemokines and the immune response to cancer. Immunity 54, 859\u2013874 (2021).","journal-title":"Immunity"},{"key":"10002_CR38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fimmu.2017.00248","volume":"8","author":"K Renner","year":"2017","unstructured":"Renner, K. et al. Metabolic hallmarks of tumor and immune cells in the tumor microenvironment. Frontiers in Immunology 8, 248 (2017).","journal-title":"Frontiers in Immunology"},{"key":"10002_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cytogfr.2018.02.003","volume":"42","author":"A Soriani","year":"2018","unstructured":"Soriani, A., Stabile, H., Gismondi, A., Santoni, A. & Bernardini, G. Chemokine regulation of innate lymphoid cell tissue distribution and function. Cytokine & Growth Factor Reviews 42, 47\u201355 (2018).","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10002_CR40","doi-asserted-by":"publisher","first-page":"153303382110689","DOI":"10.1177\/15330338211068958","volume":"20","author":"J Yan","year":"2021","unstructured":"Yan, J. et al. CCL28 downregulation attenuates pancreatic cancer progression through tumor cell-intrinsic and -extrinsic mechanisms. Technology in Cancer Research & Treatment 20, 15330338211068958 (2021).","journal-title":"Technology in Cancer Research & Treatment"},{"key":"10002_CR41","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3892\/or.2017.5798","volume":"38","author":"XL Yang","year":"2017","unstructured":"Yang, X. L., Liu, K. Y., Lin, F. J., Shi, H. M. & Ou, Z. L. CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis. Oncology Reports 38, 1393\u20131401 (2017).","journal-title":"Oncology Reports"},{"key":"10002_CR42","doi-asserted-by":"crossref","unstructured":"Sarver, D. C., Garcia-Diaz, J., Saqib, M., Riddle, R. C. & Wong, G. W. Tmem263 deletion disrupts the GH\/IGF-1 axis and causes dwarfism and impairs skeletal acquisition. Elife 12, RP90949 (2024).","DOI":"10.7554\/eLife.90949"},{"key":"10002_CR43","doi-asserted-by":"crossref","unstructured":"Stroup, B. M. et al. Delayed skeletal development and IGF-1 deficiency in a mouse model of lysinuric protein intolerance. Dis. Model Mech. 16, dmm050118(2023).","DOI":"10.1242\/dmm.050118"},{"key":"10002_CR44","doi-asserted-by":"crossref","unstructured":"Mergia Terefe, E. et al. Roles of CCR10\/CCL27\u2013CCL28 axis in tumour development: mechanisms, diagnostic and therapeutic approaches, and perspectives. Exp. Rev. Mol. Med. 24, e37 (2022).","DOI":"10.1017\/erm.2022.28"},{"key":"10002_CR45","doi-asserted-by":"crossref","unstructured":"Li, K. et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Sig. Transd. Targ. Therap. 6, 362 (2021).","DOI":"10.1038\/s41392-021-00670-9"},{"key":"10002_CR46","doi-asserted-by":"publisher","first-page":"521","DOI":"10.21873\/anticanres.16840","volume":"44","author":"JM Hong","year":"2024","unstructured":"Hong, J. M. et al. CCR10-mediated enhancement of T cell trafficking for improved tumor immunotherapy. Anticancer Research 44, 521\u2013532 (2024).","journal-title":"Anticancer Research"},{"key":"10002_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5534\/wjmh.180018","volume":"37","author":"A Bartke","year":"2019","unstructured":"Bartke, A. Growth Hormone and Aging: Updated Review. World J Mens Health 37, 19\u201330 (2019).","journal-title":"World J Mens Health"},{"key":"10002_CR48","doi-asserted-by":"crossref","unstructured":"Werner, H. et al. Genome-wide profiling of Laron syndrome patients identifies novel cancer protection pathways. Cells 8, 596 (2019).","DOI":"10.3390\/cells8060596"},{"key":"10002_CR49","doi-asserted-by":"crossref","unstructured":"Werner, H., Sarfstein, R., Nagaraj, K. & Laron, Z. Laron syndrome research paves the way for new insights in oncological investigation. Cells 9, 2446 (2020).","DOI":"10.3390\/cells9112446"},{"key":"10002_CR50","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1007\/s10637-012-9811-0","volume":"30","author":"A Gombos","year":"2012","unstructured":"Gombos, A., Metzger-Filho, O., Dal Lago, L. & Awada-Hussein, A. Clinical development of insulin-like growth factor receptor\u20131 (IGF-1R) inhibitors: at the crossroad? Invest New Drugs 30, 2433\u20132442 (2012).","journal-title":"Invest New Drugs"},{"key":"10002_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bjc.6606023","volume":"104","author":"B Basu","year":"2011","unstructured":"Basu, B., Olmos, D. & de Bono, J. S. Targeting IGF-1R: throwing out the baby with the bathwater? Br J Cancer 104, 1\u20133 (2011).","journal-title":"Br J Cancer"},{"key":"10002_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1210\/er.2006-0001","volume":"28","author":"AA Samani","year":"2007","unstructured":"Samani, A. A., Yakar, S., LeRoith, D. & Brodt, P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28, 20\u201347 (2007).","journal-title":"Endocr Rev"},{"key":"10002_CR53","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.44235","volume":"8","author":"MR Sullivan","year":"2019","unstructured":"Sullivan, M. R. et al. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. Elife 8, e44235 (2019).","journal-title":"Elife"},{"key":"10002_CR54","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/bmb.21552","volume":"49","author":"R Harshitha","year":"2021","unstructured":"Harshitha, R. & Arunraj, D. R. Real-time quantitative PCR: A tool for absolute and relative quantification. Biochem Mol Biol Educ 49, 800\u2013812 (2021).","journal-title":"Biochem Mol Biol Educ"},{"key":"10002_CR55","doi-asserted-by":"crossref","unstructured":"Plante I. Dimethylbenz(a)anthracene-induced mammary tumorigenesis in mice. Methods Cell Biol 163, 21-44 (2021).","DOI":"10.1016\/bs.mcb.2020.09.003"},{"key":"10002_CR56","unstructured":"Sozio F., Schioppa T., Sozzani S., Del Prete A. Chapter 3 - Urethane-induced lung carcinogenesis. In: Methods in Cell Biology (eds Galluzzi L, Buqu\u00e9 A). Academic Press (2021)."},{"key":"10002_CR57","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/hed.2880160506","volume":"16","author":"BL Hawkins","year":"1994","unstructured":"Hawkins, B. L. et al. 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma. Head Neck 16, 424\u2013432 (1994).","journal-title":"Head Neck"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10002-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10002-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10002-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T09:04:19Z","timestamp":1776675859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10002-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10002"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10002-8","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"539"}}